RE: Funding solved?18 Mar 2020 00:21
Hi Gettingpoorer
I view TRX like this :
The company owns some valuable assets,all of CellRight USA, the IP of both CellRight and Tissue Regenix, the Patents, the European approvals and the FDA approvals.
If there is no funding then what happens at the end of April do they just close the doors and that's it or would a larger pharma company like to buy a bargain. So what is that bargain worth, well I would say 4p a share minimum.
This investing lark is not easy but you have to know what you are investing in and TRX represents a good solid business that just needs capital to build its business, it's not in a discovery phase it's in the building a base phase, in fact it is a disruptive force in the Bio-Regenerative industry. It has products that are needed and wanted by the clinicians.
So in my opinion the upside gain is totally worth the downside risk. I may lose everything but I doubt it, so I invest.
Chester.